By Business/Source
Currency:USD
2021/FY
Stock NameRevenueRatio
Business of developing immunology and oncology therapies18.94M100.00%
By Country/Region
Currency:USD
2021/FY
Stock NameRevenueRatio
United States18.94M100.00%